Millions of obese Americans may access weight-loss drugs like Ozempic under a $35 billion Biden administration proposal awaiting Trump's approval. These injectables mimic GLP-1 hormone, aiding appetite regulation. Costly drugs could benefit millions on Medicaid and Medicare, though Trump's support remains uncertain.
Biden proposal seeks to expand access to weight-loss injectables
✨ Enjoying this article? ✨
📱 Get more with the NewsNuggs iOS App →